Universal Health Services, Inc. vs Eli Lilly & Co.
UHS vs LLY — side-by-side comparison from reported financials. UHS leads 3, LLY leads 8 of 11 comparable metrics.
Universal Health Services, Inc.
UHS · Healthcare
$177.35+0.93%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | UHS | LLY |
|---|---|---|
| Price | $177.35 | $1 177.20 |
| Market cap | $10.4B | $1.05T |
| Revenue (TTM) | $18.1B | $79.7B |
| Revenue growth | +9.0% | +31.7% |
| Net margin | 8.4% | 33.5% |
| Free cash flow | $845M | $18.2B |
| Net cash (debt) | ($3.87B) | ($35.2B) |
| 1-year price return | -12.0% | +37.6% |
| P/E | 6.8 | 41.6 |
| P/E vs own history (cheap-side %) | 93% | 88% |
| Dividend yield | 0.47% | 0.52% |
| Return on equity | 21% | 93% |
| Altman Z-score | 2.25 | 7.10 |
| CV checks passed | 11 of 11 | 11 of 11 |
| Employees | 101,500 | 50,000 |
Full résumé-style profiles: UHS CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.